The Sleeping Beauty transposon system for clinical applications

Bibliography

• Miskey C, Izsvak Z, Kawakami K, Ivics Z. DNA transposons in vertebrate functional genomics. Cell Mol Life Sci 2005;12:629-41
   Web of Science ®Google Scholar
• Ivics Z, Hackett PB, Plasterk RH, Izsvak Z. Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 1997;91:501-10
   PubMed Web of Science ®Google Scholar
• Ivics Z, Izsvak Z. The expanding universe of transposon technologies for gene and cell engineering. Mob DNA 2010;1:25
   PubMed Web of Science ®Google Scholar
• Brady T, Lee YN, Ronen K, Integration target site selection by a resurrected human endogenous retrovirus. Genes Dev 2009;23:633-42
   PubMed Web of Science ®Google Scholar
• Miskey C, Izsvak Z, Plasterk RH, Ivics Z. The Frog Prince: a reconstructed transposon from Rana pipiens with high transpositional activity in vertebrate cells. Nucleic Acids Res 2003;31:6873-81
   PubMed Web of Science ®Google Scholar
• Sinzelle L, Kapitonov VV, Grzela DP, Transposition of a reconstructed Harbinger element in human cells and functional homology with two transposon-derived cellular genes. Proc Natl Acad Sci USA 2008;105:4715-20
   PubMed Web of Science ®Google Scholar
• Cui Z, Geurts AM, Liu G, Structure-function analysis of the inverted terminal repeats of the Sleeping Beauty transposon. J Mol Biol 2002;318:1221-35
   PubMed Web of Science ®Google Scholar
• Izsvak Z, Frohlich J, Grabundzija I, Generating knockout rats by transposon mutagenesis in spermatogonial stem cells. Nat Methods 2010;7:443-5
   PubMed Web of Science ®Google Scholar
• Wilber A, Linehan JL, Tian X, Efficient and stable transgene expression in human embryonic stem cells using transposon-mediated gene transfer. Stem Cells 2007;25:2919-27
   PubMed Web of Science ®Google Scholar
• Zhu J, Kren BT, Park CW, Erythroid-specific expression of beta-globin by the sleeping beauty transposon for Sickle cell disease. Biochemistry 2007;46:6844-58
   PubMed Web of Science ®Google Scholar
• Belur LR, Frandsen JL, Dupuy AJ, Gene insertion and long-term expression in lung mediated by the Sleeping Beauty transposon system. Mol Ther 2003;8:501-7
   PubMed Web of Science ®Google Scholar
• Liu L, Sanz S, Heggestad AD, Endothelial targeting of the Sleeping Beauty transposon within lung. Mol Ther 2004;10:97-105
   PubMed Web of Science ®Google Scholar
• Bell JB, Aronovich EL, Schreifels JM, Duration of expression and activity of Sleeping Beauty transposase in mouse liver following hydrodynamic DNA delivery. Mol Ther 2010;18:1796-802
   Google Scholar
• Wu A, Oh S, Ericson K, Transposon-based interferon gamma gene transfer overcomes limitations of episomal plasmid for immunogene therapy of glioblastoma. Cancer Gene Ther 2007;14:550-60
   Google Scholar
• Izsvak Z, Hackett PB, Cooper LJ, Ivics Z. Translating Sleeping Beauty transposition into cellular therapies: victories and challenges. Bioessays 2010;32:756-67
   PubMed Web of Science ®Google Scholar
• Baus J, Liu L, Heggestad AD, Hyperactive transposase mutants of the Sleeping Beauty transposon. Mol Ther 2005;12:1148-56
   PubMed Web of Science ®Google Scholar
• Mates L, Chuah MK, Belay E, Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates. Nat Genet 2009;41:753-61
   PubMed Web of Science ®Google Scholar
• Zayed H, Izsvak Z, Walisko O, Ivics Z. Development of hyperactive sleeping beauty transposon vectors by mutational analysis. Mol Ther 2004;9:292-304
   PubMed Web of Science ®Google Scholar
• Berquam-Vrieze KE, Nannanpaneni K, Brett BT, Cell of origin strongly influences genetic selection in mouse models of T-ALL. Blood 2011;118:4646-56
   PubMed Web of Science ®Google Scholar
• Collier LS, Carlson CM, Ravimohan S, Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse. Nature 2005;436:272-6
   PubMed Web of Science ®Google Scholar
• Dupuy AJ, Akagi K, Largaespada DA, Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system. Nature 2005;436:221-6
   PubMed Web of Science ®Google Scholar
• Garrels W, Mates L, Holler S, Germline transgenic pigs by Sleeping Beauty transposition in porcine zygotes and targeted integration in the pig genome. PLoS One 2011; published online 29 August 2011; doi:10.1371/journal.pone.0023573
   Web of Science ®Google Scholar
• Ivics Z, Izsvak Z, Chapman KM, Hamra FK. Sleeping Beauty transposon mutagenesis of the rat genome in spermatogonial stem cells. Methods 2011;53:356-65
   PubMed Web of Science ®Google Scholar
• Starr TK, Allaei R, Silverstein KA, A transposon-based genetic screen in mice identifies genes altered in colorectal cancer. Science 2009;323:1747-50
   PubMed Web of Science ®Google Scholar
• Ivics Z, Izsvak Z. Transposons for gene therapy!. Curr Gene Ther 2006;6:593-607
   PubMed Web of Science ®Google Scholar
• Gene therapy clinical trials worldwide. Provided by the J Gene Med; Wiley and Sons, June 2011. Available from: www.abedia.com/wiley/index.html [Last accessed 26 November 2011]
   Google Scholar
• Montini E, Held PK, Noll M, In vivo correction of murine tyrosinemia type I by DNA-mediated transposition. Mol Ther 2002;6:759-69
   PubMed Web of Science ®Google Scholar
• Wilber A, Wangensteen KJ, Chen Y, Messenger RNA as a source of transposase for sleeping beauty transposon-mediated correction of hereditary tyrosinemia type I. Mol Ther 2007;15:1280-7
   PubMed Web of Science ®Google Scholar
• Aronovich EL, Bell JB, Belur LR, Prolonged expression of a lysosomal enzyme in mouse liver after Sleeping Beauty transposon-mediated gene delivery: implications for non-viral gene therapy of mucopolysaccharidoses. J Gene Med 2007;9:403-15
   PubMed Web of Science ®Google Scholar
• Aronovich EL, Bell JB, Khan SA, Systemic correction of storage disease in MPS I NOD/SCID mice using the sleeping beauty transposon system. Mol Ther 2009;17:1136-44
   PubMed Web of Science ®Google Scholar
• Chen ZJ, Kren BT, Wong PY, Sleeping Beauty-mediated down-regulation of huntingtin expression by RNA interference. Biochem Biophys Res Commun 2005;329:646-52
   PubMed Web of Science ®Google Scholar
• Belcher JD, Vineyard JV, Bruzzone CM, Heme oxygenase-1 gene delivery by Sleeping Beauty inhibits vascular stasis in a murine model of sickle cell disease. J Mol Med 2010;88:665-75
   PubMed Web of Science ®Google Scholar
• Liu L, Liu H, Visner G, Fletcher BS. Sleeping Beauty-mediated eNOS gene therapy attenuates monocrotaline-induced pulmonary hypertension in rats. FASEB J 2006;20:2594-6
   PubMed Web of Science ®Google Scholar
• Tamhane M, Akkina R. Stable gene transfer of CCR5 and CXCR4 siRNAs by sleeping beauty transposon system to confer HIV-1 resistance. AIDS Res Ther 2008;5:16
   PubMedGoogle Scholar
• Liu H, Liu L, Fletcher BS, Visner GA. Sleeping Beauty-based gene therapy with indoleamine 2,3-dioxygenase inhibits lung allograft fibrosis. FASEB J 2006;20:2384-6
   PubMed Web of Science ®Google Scholar
• Liu L, Mah C, Fletcher BS. Sustained FVIII expression and phenotypic correction of hemophilia A in neonatal mice using an endothelial-targeted sleeping beauty transposon. Mol Ther 2006;13:1006-15
   PubMed Web of Science ®Google Scholar
• Ohlfest JR, Frandsen JL, Fritz S, Phenotypic correction and long-term expression of factor VIII in hemophilic mice by immunotolerization and nonviral gene transfer using the Sleeping Beauty transposon system. Blood 2005;105:2691-8
   PubMed Web of Science ®Google Scholar
• Kren BT, Unger GM, Sjeklocha L, Nanocapsule-delivered Sleeping Beauty mediates therapeutic Factor VIII expression in liver sinusoidal endothelial cells of hemophilia A mice. J Clin Invest 2009;119:2086-99
   PubMed Web of Science ®Google Scholar
• Liu L, Liu H, Mah C, Fletcher BS. Indoleamine 2,3-dioxygenase attenuates inhibitor development in gene-therapy-treated hemophilia A mice. Gene Ther 2009;16:724-33
   PubMed Web of Science ®Google Scholar
• Hausl MA, Zhang W, Muther N, Hyperactive sleeping beauty transposase enables persistent phenotypic correction in mice and a canine model for hemophilia B. Mol Ther 2010;18:1896-906
   PubMed Web of Science ®Google Scholar
• Yant SR, Meuse L, Chiu W, Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system. Nat Genet 2000;25:35-41
   PubMed Web of Science ®Google Scholar
• Belur LR, Podetz-Pedersen KM, Sorenson BS, Inhibition of angiogenesis and suppression of colorectal cancer metastatic to the liver using the Sleeping Beauty Transposon System. Mol Cancer 2011;10:14
   PubMed Web of Science ®Google Scholar
• Ohlfest JR, Demorest ZL, Motooka Y, Combinatorial antiangiogenic gene therapy by nonviral gene transfer using the sleeping beauty transposon causes tumor regression and improves survival in mice bearing intracranial human glioblastoma. Mol Ther 2005;12:778-88
   PubMed Web of Science ®Google Scholar
• Song J, Kim C, Ochoa ER. Sleeping Beauty-mediated suicide gene therapy of hepatocellular carcinoma. Biosci Biotechnol Biochem 2009;73:165-8
   PubMed Web of Science ®Google Scholar
• Huang X, Guo H, Kang J, Sleeping Beauty transposon-mediated engineering of human primary T cells for therapy of CD19+ lymphoid malignancies. Mol Ther 2008;16:580-9
   PubMed Web of Science ®Google Scholar
• Williams DA. Sleeping beauty vector system moves toward human trials in the United States. Mol Ther 2008;16:1515-16
   PubMed Web of Science ®Google Scholar
• Singh H, Manuri PR, Olivares S, Redirecting specificity of T-cell populations for CD19 using the Sleeping Beauty system. Cancer Res 2008;68:2961-71
   PubMed Web of Science ®Google Scholar
• Jin Z, Maiti S, Huls H, The hyperactive Sleeping Beauty transposase SB100X improves the genetic modification of T cells to express a chimeric antigen receptor. Gene Ther 2011;18:849-56
   PubMed Web of Science ®Google Scholar
• Alba R, Bosch A, Chillon M. Gutless adenovirus: last-generation adenovirus for gene therapy. Gene Ther 2005;12(Suppl 1):S18-27
   PubMed Web of Science ®Google Scholar
• Cuchet D, Potel C, Thomas J, Epstein AL. HSV-1 amplicon vectors: a promising and versatile tool for gene delivery. Expert Opin Biol Ther 2007;7:975-95
   PubMed Web of Science ®Google Scholar
• McCarty DM, Young SM Jr, Samulski RJ. Integration of adeno-associated virus (AAV) and recombinant AAV vectors. Annu Rev Genet 2004;38:819-45
   PubMed Web of Science ®Google Scholar
• Yi Y, Hahm SH, Lee KH. Retroviral gene therapy: safety issues and possible solutions. Curr Gene Ther 2005;5:25-35
   PubMed Web of Science ®Google Scholar
• Herweijer H, Wolff JA. Progress and prospects: naked DNA gene transfer and therapy. Gene Ther 2003;10:453-8
   PubMed Web of Science ®Google Scholar
• Mitchell RS, Beitzel BF, Schroder AR, Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol 2004;2:E234
   PubMed Web of Science ®Google Scholar
• Avedillo Diez I, Zychlinski D, Coci EG, Development of novel efficient SIN vectors with improved safety features for Wiskott-Aldrich syndrome stem cell based gene therapy. Mol Pharm 2011;8:1525-37
   PubMed Web of Science ®Google Scholar
• Wu X, Li Y, Crise B, Burgess SM. Transcription start regions in the human genome are favored targets for MLV integration. Science 2003;300:1749-51
   PubMed Web of Science ®Google Scholar
• Izsvak Z, Chuah MK, Vandendriessche T, Ivics Z. Efficient stable gene transfer into human cells by the Sleeping Beauty transposon vectors. Methods 2009;49:287-97
   PubMed Web of Science ®Google Scholar
• Geurts AM, Yang Y, Clark KJ, Gene transfer into genomes of human cells by the Sleeping Beauty transposon system. Mol Ther 2003;8:108-17
   PubMed Web of Science ®Google Scholar
• Grabundzija I, Irgang M, Mates L, Comparative analysis of transposable element vector systems in human cells. Mol Ther 2010;18:1200-9
   PubMed Web of Science ®Google Scholar
• Galla M, Schambach A, Falk CS, Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery. Nucleic Acids Res 2011;39:7147-60
   PubMed Web of Science ®Google Scholar
• Wilber A, Frandsen JL, Geurts JL, RNA as a source of transposase for Sleeping Beauty-mediated gene insertion and expression in somatic cells and tissues. Mol Ther 2006;13:625-30
   PubMed Web of Science ®Google Scholar
• Izsvak Z, Ivics Z, Plasterk RH. Sleeping Beauty, a wide host-range transposon vector for genetic transformation in vertebrates. J Mol Biol 2000;302:93-102
   PubMed Web of Science ®Google Scholar
• Sjeklocha L, Chen Y, Daly MC, beta-globin matrix attachment region improves stable genomic expression of the Sleeping beauty transposon. J Cell Biochem 2011;112:2361-75
   PubMed Web of Science ®Google Scholar
• Walisko O, Schorn A, Rolfs F, Transcriptional activities of the Sleeping Beauty transposon and shielding its genetic cargo with insulators. Mol Ther 2008;16:359-69
   PubMed Web of Science ®Google Scholar
• Garrison BS, Yant SR, Mikkelsen JG, Kay MA. Postintegrative gene silencing within the Sleeping Beauty transposition system. Mol Cell Biol 2007;27:8824-33
   PubMed Web of Science ®Google Scholar
• Dalsgaard T, Moldt B, Sharma N, Shielding of sleeping beauty DNA transposon-delivered transgene cassettes by heterologous insulators in early embryonal cells. Mol Ther 2009;17:121-30
   Google Scholar
• Rad R, Rad L, Wang W, PiggyBac transposon mutagenesis: a tool for cancer gene discovery in mice. Science 2010;330:1104-7
   PubMed Web of Science ®Google Scholar
• Sumiyoshi T, Holt NG, Hollis RP, Stable transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells, using the Sleeping Beauty transposon system. Hum Gene Ther 2009;20:1607-26
   PubMed Web of Science ®Google Scholar
• Xue X, Huang X, Nodland SE, Stable gene transfer and expression in cord blood-derived CD34+ hematopoietic stem and progenitor cells by a hyperactive Sleeping Beauty transposon system. Blood 2009;114:1319-30
   PubMed Web of Science ®Google Scholar
• Lin EH, Keramidas M, Rome C, Lifelong reporter gene imaging in the lungs of mice following polyethyleneimine-mediated sleeping-beauty transposon delivery. Biomaterials 2011;32:1978-85
   PubMed Web of Science ®Google Scholar
• Podetz-Pedersen KM, Bell JB, Steele TW, Gene expression in lung and liver after intravenous infusion of polyethylenimine complexes of Sleeping Beauty transposons. Hum Gene Ther 2010;21:210-20
   PubMed Web of Science ®Google Scholar
• Wang X, Sarkar DP, Mani P, Long-term reduction of jaundice in Gunn rats by nonviral liver-targeted delivery of Sleeping Beauty transposon. Hepatology 2009;50:815-24
   PubMed Web of Science ®Google Scholar
• Belur LR, McIvor RS, Wilber A. Liver-directed gene therapy using the sleeping beauty transposon system. Methods Mol Biol 2008;434:267-76
   PubMedGoogle Scholar
• Brunetti-Pierri N, Palmer DJ, Beaudet AL, Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates. Hum Gene Ther 2004;15:35-46
   PubMed Web of Science ®Google Scholar
• Bell JB, Podetz-Pedersen KM, Aronovich EL, Preferential delivery of the Sleeping Beauty transposon system to livers of mice by hydrodynamic injection. Nat Protoc 2007;2:3153-65
   PubMed Web of Science ®Google Scholar
• Moldt B, Miskey C, Staunstrup NH, Comparative Genomic integration profiling of Sleeping Beauty transposons mobilized with high efficacy from integrase-defective lentiviral vectors in primary human cells. Mol Ther 2011;19:1499-510
   PubMed Web of Science ®Google Scholar
• Staunstrup NH, Moldt B, Mates L, Hybrid lentivirus-transposon vectors with a random integration profile in human cells. Mol Ther 2009;17:1205-14
   PubMed Web of Science ®Google Scholar
• Vink CA, Gaspar HB, Gabriel R, Sleeping Beauty transposition from nonintegrating lentivirus. Mol Ther 2009;17:1197-204
   PubMed Web of Science ®Google Scholar
• de Silva S, Mastrangelo MA, Lotta LT Jr, Extending the transposable payload limit of Sleeping Beauty (SB) using the Herpes Simplex Virus (HSV)/SB amplicon-vector platform. Gene Ther 2010;17:424-31
   PubMed Web of Science ®Google Scholar
• Yant SR, Ehrhardt A, Mikkelsen JG, Transposition from a gutless adeno-transposon vector stabilizes transgene expression in vivo. Nat Biotechnol 2002;20:999-1005
   PubMed Web of Science ®Google Scholar
• Hacein-Bey-Abina S, Garrigue A, Wang GP, Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest 2008;118:3132-42
   PubMed Web of Science ®Google Scholar
• Ott MG, Schmidt M, Schwarzwaelder K, Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med 2006;12:401-9
   PubMed Web of Science ®Google Scholar
• Liu G, Geurts AM, Yae K, Target-site preferences of Sleeping Beauty transposons. J Mol Biol 2005;346:161-73
   PubMed Web of Science ®Google Scholar
• Vigdal TJ, Kaufman CD, Izsvak Z, Common physical properties of DNA affecting target site selection of sleeping beauty and other Tc1/mariner transposable elements. J Mol Biol 2002;323:441-52
   PubMed Web of Science ®Google Scholar
• Huang X, Guo H, Tammana S, Gene transfer efficiency and genome-wide integration profiling of Sleeping Beauty, Tol2, and piggyBac transposons in human primary T cells. Mol Ther 2010;18:1803-13
   PubMed Web of Science ®Google Scholar
• Yant SR, Wu X, Huang Y, High-resolution genome-wide mapping of transposon integration in mammals. Mol Cell Biol 2005;25:2085-94
   PubMed Web of Science ®Google Scholar
• Izsvak Z, Stuwe EE, Fiedler D, Healing the wounds inflicted by Sleeping Beauty transposition by double-strand break repair in mammalian somatic cells. Mol Cell 2004;13:279-90
   PubMed Web of Science ®Google Scholar
• Yant SR, Kay MA. Nonhomologous-end-joining factors regulate DNA repair fidelity during Sleeping Beauty element transposition in mammalian cells. Mol Cell Biol 2003;23:8505-18
   PubMed Web of Science ®Google Scholar
• Ivics Z, Katzer A, Stuwe EE, Targeted Sleeping Beauty transposition in human cells. Mol Ther 2007;15:1137-44
   PubMed Web of Science ®Google Scholar
• Wilson MH, Kaminski JM, George AL Jr. Functional zinc finger/sleeping beauty transposase chimeras exhibit attenuated overproduction inhibition. FEBS Lett 2005;579:6205-9
   PubMed Web of Science ®Google Scholar
• Yant SR, Huang Y, Akache B, Kay MA. Site-directed transposon integration in human cells. Nucleic Acids Res 2007;35:e50
   PubMed Web of Science ®Google Scholar
• Handel EM, Cathomen T. Zinc-finger nuclease based genome surgery: it's all about specificity. Curr Gene Ther 2011;11:28-37
   PubMed Web of Science ®Google Scholar
• Boch J, Scholze H, Schornack S, Breaking the code of DNA binding specificity of TAL-type III effectors. Science 2009;326:1509-12
   PubMed Web of Science ®Google Scholar
• Miller JC, Tan S, Qiao G, A TALE nuclease architecture for efficient genome editing. Nat Biotechnol 2011;29:143-8
   PubMed Web of Science ®Google Scholar
• Boitano AE, Wang J, Romeo R, Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 2010;329:1345-8
   PubMed Web of Science ®Google Scholar
• Zychlinski D, Schambach A, Modlich U, Physiological promoters reduce the genotoxic risk of integrating gene vectors. Mol Ther 2008;16:718-25
   PubMed Web of Science ®Google Scholar
• Peng PD, Cohen CJ, Yang S, Efficient nonviral Sleeping Beauty transposon-based TCR gene transfer to peripheral blood lymphocytes confers antigen-specific antitumor reactivity. Gene Ther 2009;16:1042-9
   PubMed Web of Science ®Google Scholar
• Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000;288:669-72
   PubMed Web of Science ®Google Scholar
• Gaspar HB, Parsley KL, Howe S, Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet 2004;364:2181-7
   PubMed Web of Science ®Google Scholar
• Aiuti A, Slavin S, Aker M, Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 2002;296:2410-13
   PubMed Web of Science ®Google Scholar
• Hollis RP, Nightingale SJ, Wang X, Stable gene transfer to human CD34+ hematopoietic cells using the Sleeping Beauty transposon. Exp Hematol 2006;34:1333-43
   PubMed Web of Science ®Google Scholar
• Enquist IB, Nilsson E, Mansson JE, Successful low-risk hematopoietic cell therapy in a mouse model of type 1 Gaucher disease. Stem Cells 2009;27:744-52
   PubMed Web of Science ®Google Scholar
• Ryser MF, Roesler J, Gentsch M, Brenner S. Gene therapy for chronic granulomatous disease. Expert Opin Biol Ther 2007;7:1799-809
   PubMed Web of Science ®Google Scholar
• Hyland KA, Olson ER, Clark KJ, Sleeping Beauty-mediated correction of Fanconi anemia type C. J Gene Med 2011;13:462-9
   PubMed Web of Science ®Google Scholar
• Mayrhofer P, Schleef M, Jechlinger W. Use of minicircle plasmids for gene therapy. Methods Mol Biol 2009;542:87-104
   PubMedGoogle Scholar
• Brunetti-Pierri N, Stapleton GE, Palmer DJ, Pseudo-hydrodynamic delivery of helper-dependent adenoviral vectors into non-human primates for liver-directed gene therapy. Mol Ther 2007;15:732-40
   PubMed Web of Science ®Google Scholar
• Aronovich EL, McIvor RS, Hackett PB. The Sleeping Beauty transposon system: a non-viral vector for gene therapy. Hum Mol Genet 2011;20:R14-20
   PubMed Web of Science ®Google Scholar
• Hackett PB, Largaespada DA, Cooper LJ. A transposon and transposase system for human application. Mol Ther 2010;18:674-83
   PubMed Web of Science ®Google Scholar